Adial Pharmaceuticals Inc (NASDAQ: ADIL) today announced that it had obtained correspondence related to its application for Fast Track Designation from the U.S. Food and Drug Administration (FDA) for its medicine candidate, AD04. The candidate will be used to cure Alcohol Use Disorder (AUD) in pediatric patients and adult patients […]